Literature DB >> 30134165

PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior.

Yan Wang1, Cheng Zeng2, Jinchen Li3, Zikai Zhou4, Xingda Ju5, Shuting Xia4, Yuanyuan Li2, An Liu4, Huajing Teng1, Kun Zhang6, Leisheng Shi6, Cheng Bi1, Wei Xie4, Xin He7, Zhengping Jia8, Yonghui Jiang9, Tao Cai10, Jinyu Wu6, Kun Xia11, Zhong Sheng Sun12.   

Abstract

Synaptic cytoskeleton dysfunction represents a common pathogenesis in neurodevelopmental disorders, such as autism spectrum disorder (ASD). The serine/threonine kinase PAK2 is a critical regulator of cytoskeleton dynamics. However, its function within the central nervous system and its role in ASD pathogenesis remain undefined. Here, we found that Pak2 haploinsufficiency resulted in markedly decreased synapse densities, defective long-term potentiation, and autism-related behaviors in mice. Phosphorylation levels of key actin regulators LIMK1 and cofilin, together with their mediated actin polymerization, were reduced in Pak2+/-mice. We identified one de novo PAK2 nonsense mutation that impaired PAK2 function in vitro and in vivo and four de novo copy-number deletions containing PAK2 in large cohorts of patients with ASD. PAK2 deficiency extensively perturbed functional networks associated with ASD by regulating actin cytoskeleton dynamics. Our genetic and functional results demonstrate a critical role of PAK2 in brain development and autism pathogenesis.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LIMK1; PAK2; actin cytoskeleton; autism; cofilin

Mesh:

Substances:

Year:  2018        PMID: 30134165     DOI: 10.1016/j.celrep.2018.07.061

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  20 in total

1.  Co-expression Network of mRNAs and lncRNAs Regulated by Stress-Linked Behavioral Assays.

Authors:  Jianghong Zhang; Meiying Xue; Yue Mei; Zhigang Li; Zeng Ceng; Yuanyuan Li; Yi Zhang; Na Li; Huajing Teng; Zhong Sheng Sun; Yan Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-11-23       Impact factor: 4.530

Review 2.  AR-dependent phosphorylation and phospho-proteome targets in prostate cancer.

Authors:  Varadha Balaji Venkadakrishnan; Salma Ben-Salem; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

3.  NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.

Authors:  Mayanglambam Dhruba Singh; Matthew Jensen; Micaela Lasser; Emily Huber; Tanzeen Yusuff; Lucilla Pizzo; Brian Lifschutz; Inshya Desai; Alexis Kubina; Sneha Yennawar; Sydney Kim; Janani Iyer; Diego E Rincon-Limas; Laura Anne Lowery; Santhosh Girirajan
Journal:  PLoS Genet       Date:  2020-02-13       Impact factor: 5.917

Review 4.  Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.

Authors:  Yan Wang; Fuzheng Guo
Journal:  Biol Rev Camb Philos Soc       Date:  2021-11-22

5.  System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration.

Authors:  Jeffrey L Brabec; Montana Kay Lara; Anna L Tyler; J Matthew Mahoney
Journal:  Front Genet       Date:  2021-04-06       Impact factor: 4.599

6.  Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome.

Authors:  Esra Sefik; Ryan H Purcell; Elaine F Walker; Gary J Bassell; Jennifer G Mulle
Journal:  Transl Psychiatry       Date:  2021-06-15       Impact factor: 6.222

Review 7.  Dissecting the complexity of CNV pathogenicity: insights from Drosophila and zebrafish models.

Authors:  Tanzeen Yusuff; Georgios Kellaris; Santhosh Girirajan; Nicholas Katsanis
Journal:  Curr Opin Genet Dev       Date:  2021-03-31       Impact factor: 4.665

8.  A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.

Authors:  Haixia Zhang; Bingwu Xiang; Hui Chen; Xiang Chen; Tao Cai
Journal:  BMC Med Genet       Date:  2019-03-06       Impact factor: 2.103

9.  Prenylated quinolinecarboxylic acid compound-18 prevents sensory nerve fiber outgrowth through inhibition of the interleukin-31 pathway.

Authors:  Masato Ogura; Kumiko Endo; Toshiyuki Suzuki; Yoshimi Homma
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 10.  Rho GTPase Regulators and Effectors in Autism Spectrum Disorders: Animal Models and Insights for Therapeutics.

Authors:  Daji Guo; Xiaoman Yang; Lei Shi
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.